Valued at $19.9M at its early-stage round, Jan 2025. Nothing has traded since.
- ·Watch Oral Genome: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Oral Genome funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2025 | Seed Round | $3.1M | ▮ | ▮ |
| Sep 2022 | Accelerator/Incubator | — | ▮ | ▮ |
Membership and data by Private Market View
Oral Genome valuation
Oral Genome was valued at $19.9 million at its early-stage round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Oral Genome raised?
Oral Genome has raised $4.4 million in total; 2 of its rounds are on record. The largest on record was a $3.1 million seed round in Jan 2025.
Oral Genome has filed 4 Form Ds with the SEC since 2021, most recently in Jan 2025 ($3.1 million sold to 37 investors).
Comparable companies
Comparable diagnostic equipment names by valuation on PrivateMarketView: NanoMosaic ($85 million), AOA (Diagnostic Equipment) ($65 million) and WavelyDx ($11.3 million).
How Oral Genome's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Oral Genome, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Oral Genome
- What is Oral Genome worth?
- Oral Genome is valued at $19.9M as of Oct 2026. Valued at $19.9M at its early-stage round, Jan 2025. Nothing has traded since.
- How much has Oral Genome raised?
- Oral Genome has raised $4.4M in total funding across 2 recorded rounds.
- When did Oral Genome last raise?
- Oral Genome last raised in Jan 2025 (Seed Round), raising $3.1M.